Valproate, a Mood Stabilizer, Induces WFS1 Expression and Modulates Its Interaction with ER Stress Protein GRP94
Open Access
- 6 January 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (1), e4134
- https://doi.org/10.1371/journal.pone.0004134
Abstract
Valproate is a standard treatment for bipolar disorder and a first-line mood stabilizer. The molecular mechanisms underlying its actions in bipolar disorder are unclear. It has been suggested that the action of valproate is linked to changes in gene expression and induction of endoplasmic reticulum (ER) stress-response proteins. Here we show that valproate modulates the ER stress response through the regulation of WFS1, an important component for mitigating ER stress. Therapeutic concentrations of valproate induce expression of WFS1 mRNA and activate the WFS1 promoter. In addition, WFS1 forms a complex with GRP94, an ER stress-response protein, in which valproate dose-dependently enhances its dissociation from GRP94. These results suggest that the therapeutic effects of valproate in bipolar disorder may be mediated by WFS1 expression and its dissociation from GRP94.Keywords
This publication has 23 references indexed in Scilit:
- OS-9 and GRP94 deliver mutant α1-antitrypsin to the Hrd1–SEL1L ubiquitin ligase complex for ERADNature, 2008
- Valproate: Past, Present, and FutureCNS Drug Reviews, 2003
- Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and TeratogenJournal of Biological Chemistry, 2001
- Mechanisms of action of valproate: a commentatoryNeurochemistry International, 2000
- A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)Nature Genetics, 1998
- Geldanamycin, an hsp90/GRP94-binding drug, induces increased transcription of endoplasmic reticulum (ER) chaperones via the ER stress pathwayJournal of Cellular Physiology, 1998
- Predisposition of Wolfram syndrome heterozygotes to psychiatric illnessMolecular Psychiatry, 1998
- Increase in AP-1 Transcription Factor DNA Binding Activity by Valproic AcidNeuropsychopharmacology, 1997
- Psychiatric findings in Wolfram syndrome homozygotesThe Lancet, 1990
- The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteinsNature, 1988